Hereditary Cancer Group is a multidisciplinary research group working on Hereditary Cancer at the Bellvitge Biomedical Research Institute (IDIBELL). Our work, whether clinical- or research-oriented, is focused on the improvement of healthcare of patients with a personal or a family history of cancer. The overarching goal of our research activity is to gain insight into the molecular bases of hereditary cancer -with a particular interest in gastrointestinal cancer, Hereditary Breast and Ovarian Cancer and Rare Tumor predisposing syndromes – to improve genetic diagnosis and to personalize risk assessment for patients and relatives, as well as to individualize management regarding follow-up, treatment, and prophylactic and preventive measures. The group participates in international and national initiatives aimed to improve variant classification in hereditary cancer genes, define clinical guidelines for hereditary cancer patients, and implement genomic-based personalized medicine in the National Health System.
The aim is to advance insights into the dynamic evolution of gastrointestinal tumors and to prelimin...
Database for sharing genetic variants in hereditary cancer genes and their interpretation from exper...
IMPaCT-VUScan is an initiative that aims to identify variants of unknown si...
The overarching goal of our research activity is to gain insight into the molecular bases of hereditary cancer to improve genetic diagnosis, to personalize risk assessment, and to individualize management regarding follow-up, treatment, and prophylactic and preventive measures. We are mainly focus on gastrointestinal cancer, Hereditary Breast and Ovarian Cancer and Rare Tumor predisposing syndromes.
5 research teams
Clinical Genetics Lab Dr. Conxi Lázaro
Colorectal Cancer Predisposition Lab Dr. Laura Valle
DNA MisMatch Repair Lab Dr. Marta Pineda, Dr. Gabriel Capellá
Global Projects Support Team
Rare TumorS Lab Dr. Bárbara Rivera
Clinical Genetics Lab
Dr. Conxi LázaroClinical Genetics Lab
Dr. Lázaro’s team is focused on genetic analysis of human diseases and specifically on improving the tools for mutational analysis for diagnostic purposes using comprehensive approaches. In...
Dr. Conxi Lázaro
clazaro@iconcologia.net
Learn more about this research
Colorectal Cancer Predisposition Lab
Dr. Laura ValleColorectal Cancer Predisposition Lab
The research of the Colorectal Cancer Predisposition Group, led by Dr. Laura Valle, is focused on the identification of the genetic causes of colorectal cancer predisposition, and the characterizat...
Dr. Laura Valle
lvalle@idibell.cat
Learn more about this research
DNA MisMatch Repair Lab
Dr. Marta Pineda, Dr. Gabriel CapelláDNA MisMatch Repair Lab
The research activity of the DNA Mismatch Repair group, led by Dr. Gabriel Capellá and Marta Pineda, is focused on the improvement of healthcare of patients with mismatch repair associated heredit...
Dr. Marta Pineda, Dr. Gabriel Capellá
mpineda@iconcologia.net
Learn more about this research
Global Projects
Support TeamGlobal Projects
The Hereditary Cancer Group at IDIBELL is involved in several global projects, involving regional, national and international initiatives of genomic-based precision medicine in cancer.
...
Support Team
Learn more about this research
Rare TumorS Lab
Dr. Bárbara RiveraRare TumorS Lab
Why some patients develop rare tumors? Why do they develop both benign and malignant tumors? The main research focus of the Rare Tumor Syndromes’ Laboratory is the molecular and clinical characte...
Dr. Bárbara Rivera
brivera@idibell.cat
Learn more about this research
Clinical Genetics Lab
Dr. Lázaro’s team is focused on genetic analysis of human diseases and specifically on improving the tools for mutational analysis for diagnostic purposes using comprehensive approaches. In...
Dr. Conxi Lázaro
clazaro@iconcologia.net
Learn more
Colorectal Cancer Predisposition Lab
The research of the Colorectal Cancer Predisposition Group, led by Dr. Laura Valle, is focused on the identification of the genetic causes of colorectal cancer predisposition, and the characterizat...
Dr. Laura Valle
lvalle@idibell.cat
Learn more
DNA MisMatch Repair Lab
The research activity of the DNA Mismatch Repair group, led by Dr. Gabriel Capellá and Marta Pineda, is focused on the improvement of healthcare of patients with mismatch repair associated heredit...
Dr. Marta Pineda, Dr. Gabriel Capellá
mpineda@iconcologia.net
Learn more
Global Projects
The Hereditary Cancer Group at IDIBELL is involved in several global projects, involving regional, national and international initiatives of genomic-based precision medicine in cancer.
...
Support Team
Learn more
Rare TumorS Lab
Why some patients develop rare tumors? Why do they develop both benign and malignant tumors? The main research focus of the Rare Tumor Syndromes’ Laboratory is the molecular and clinical characte...
Dr. Bárbara Rivera
brivera@idibell.cat
Learn more
They develop a new highly sensitive method that combines massive sequencing of the genetic material of patients and subsequent bioinformatic...
Colon polyps are premalignant lesions, that is, they are not initially dangerous, but in the absence of proper clinical management...
Approximately 10% of cancers can be attributed to genetic variants present in all patient’s cells since birth. These variants predispose...
A team of researchers, led by IDIBELL and the Catalan Institute of Oncology (ICO), presents the results of a screening...
